Effect of etanercept on refractory systemic-onset juvenile idiopathic arthritis

World Journal of Pediatrics : WJP
Xiao HuYan-Liang Jin

Abstract

Treatment of systemic-onset juvenile idiopathic arthritis (So-JIA) is challenging, and the efficacy of injectable recombinant human tumor necrosis factor type 1 receptor-antibody fusion protein (etanercept) on So-JIA has been controversial. We retrospectively studied 12 patients with refractory systemic juvenile arthritis treated with etanercept at our hospital in the past 5 years. The 12 patients were divided into a corticosteroid-dependent group (n=7) and an ineffective group (n=5) on the basis of their responses to treatment before the administration of etanercept. Etanercept was added to the treatment without substantially changing the original regimens in general, and doses, and signs of efficacy including alleviation or resolution of symptoms such as high fever, inflammatory arthropathy, eruption rash, hydrohymenitis, as well as changes in the levels of laboratory inflammatory markers such as the white blood cell count, erythrocyte sedimentation rate, levels of C-reactive protein and serum ferritin were recorded. Etanercept was withdrawn after the first dose from one patient in the corticosteroid-dependent group because of a systemic allergic rash, and was also withdrawn from one patient in the ineffective group after 2 m...Continue Reading

References

Oct 2, 2002·Arthritis and Rheumatism·Kirsten MindenAngela Zink
Apr 11, 2003·Arthritis and Rheumatism·Pierre QuartierAnne-Marie Prieur
Apr 30, 2004·Annals of the Rheumatic Diseases·G HorneffUNKNOWN Paediatric Rheumatology Collaborative Group
Aug 12, 2005·Current Opinion in Rheumatology·Alexa Adams, Thomas J A Lehman
Mar 6, 2007·Lancet·Angelo Ravelli, Alberto Martini
Oct 21, 2011·Expert Opinion on Drug Safety·Giuseppe MurdacaFrancesco Puppo
Dec 21, 2012·The New England Journal of Medicine·Fabrizio De BenedettiUNKNOWN PRCSG
Jan 22, 2013·Expert Opinion on Drug Safety·Giuseppe MurdacaFrancesco Puppo
Mar 25, 2014·Expert Opinion on Drug Safety·Giuseppe MurdacaFrancesco Puppo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
Julio García Feito, C A Pereda
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Ho-Chang KuoKuender D Yang
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Tong-Xin HanJiang-Hong Deng
© 2022 Meta ULC. All rights reserved